FDA Approves Accord’s Higher Strength Herceptin Biosimilar

The Two Approvals Pave The Way To A Launch In Early 2025

 
• By Adam Zamecnik
  
FDA sign
• Source: Shutterstock

More from Products

More from Generics Bulletin